Intratumoral CAN2109 in Subjects With Solid Tumors
NCT06332430
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Lymphoma
Interventions
DRUG:
CAN2109
Sponsor
Canwell Biotech Limited